Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
Top Cited Papers
Open Access
- 30 March 2020
- journal article
- review article
- Published by The Korean Society of Gastrointestinal Endoscopy in Clinical Endoscopy
- Vol. 53 (2), 142-166
- https://doi.org/10.5946/ce.2020.032
Abstract
Although surgery was the standard treatment for early gastrointestinal cancers, endoscopic resection is now a standard treatment for early gastrointestinal cancers without regional lymph node metastasis. High-definition white light endoscopy, chromoendoscopy, and image-enhanced endoscopy such as narrow band imaging are performed to assess the edge and depth of early gastrointestinal cancers for delineation of resection boundaries and prediction of the possibility of lymph node metastasis before the decision of endoscopic resection. Endoscopic mucosal resection and/or endoscopic submucosal dissection can be performed to remove early gastrointestinal cancers completely by en bloc fashion. Histopathological evaluation should be carefully made to investigate the presence of risk factors for lymph node metastasis such as depth of cancer invasion and lymphovascular invasion. Additional treatment such as radical surgery with regional lymphadenectomy should be considered if the endoscopically resected specimen shows risk factors for lymph node metastasis. This is the first Korean clinical practice guideline for endoscopic resection of early gastrointestinal cancer. This guideline was developed by using mainly de novo methods and encompasses endoscopic management of superficial esophageal squamous cell carcinoma, early gastric cancer, and early colorectal cancer. This guideline will be revised as new data on early gastrointestinal cancer are collected.Keywords
This publication has 258 references indexed in Scilit:
- Role of antisecretory agents for gastric endoscopic submucosal dissectionDigestive Endoscopy, 2013
- Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection–induced ulcers? A randomized, prospective, multicenter studyGastrointestinal Endoscopy, 2012
- Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissectionJournal of Gastroenterology and Hepatology, 2012
- Immunohistochemical Assessment of Lymphovascular Invasion in Stage I Colorectal CarcinomaThe American Journal of Surgical Pathology, 2012
- Optimal Duration of Proton Pump Inhibitor in the Treatment of Endoscopic Submucosal Dissection-Induced Ulcers: A Retrospective Analysis and Prospective Validation StudyDigestive Diseases and Sciences, 2011
- Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasiaThe Esophagus, 2011
- PROSPECTIVE SINGLE-ARM TRIAL OF TWO-WEEK RABEPRAZOLE TREATMENT FOR ULCER HEALING AFTER GASTRIC ENDOSCOPIC SUBMUCOSAL DISSECTIONDigestive Endoscopy, 2011
- A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissectionThe Esophagus, 2011
- A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508Japanese Journal of Clinical Oncology, 2009
- Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trialThe Lancet, 2008